Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Pediatric Drugs
Erschienen in: Pediatric Drugs 5/2003

01.05.2003 | Therapy In Practice

Guidelines for the Management of Acne Vulgaris in Adolescents

verfasst von: Dr Victoria Goulden

Erschienen in: Pediatric Drugs | Ausgabe 5/2003

Einloggen, um Zugang zu erhalten

Abstract

This article reviews the treatment of acne in adolescents. The choice of therapy should be principally based on the type of lesion and the severity of the acne, but psychosocial disability relating to the disease and the presence of scarring may also influence the approach to treatment.
Mild acne generally requires topical treatment only. Benzoyl peroxide, azelaic acid, and antibacterials are generally used for inflammatory lesions. Topical retinoids are particularly effective for noninflamed lesions, and combination therapies are useful for mixed lesions.
Moderately severe acne generally requires oral antibacterials. Tetracyclines/oxytetracycline and erythromycin are usually the first-line antibacterials. Second-generation tetracyclines, such as lymecycline, doxycycline, and minocycline, show improved absorption. Minocycline has the advantage of being rarely associated with Propionibacterium acnes antibacterial resistance, but can occasionally lead to potentially serious adverse effects. Trimethoprim is a useful third-line antibacterial therapy for patients resistant to other antibacterial therapies. Benzoyl peroxide should generally be used in combination with oral antibacterials as this has been shown to reduce the development of antibacterial resistance.
For severe nodular acne, isotretinoin is the treatment of choice. In addition, over recent years dermatologists have increasingly used this drug to treat patients with moderate acne which has not responded to other systemic therapies, particularly when associated with scarring or significant psychological disability. However, this use is outside the current license of the drug. Isotretinoin is associated with a number of serious adverse effects and careful monitoring of patients during therapy is required.
Physical therapies for the treatment of acne nodules and macrocomedones are also important adjuncts to drug therapies.
Fußnoten
1
The use of tradenames is for product identification purposes only and does not imply endorsement.
 
Literatur
1.
Lello J, Pearl A, Arroll B, et al. Prevalence of acne vulgaris in Auckland senior high school students. NZ Med J 1995; 108: 287–9
2.
Lucky AW, Biro FM, Huster FA. Acne vulgaris in early adolescent boys: correlation between pubertal maturation and age. Arch Dermatol 1991; 172: 210–6CrossRef
3.
Rademaker M, Gariosch JJ, Simpson NB. Acne in schoolchildren: no longer a cause for concern for dermatologists. BMJ 1989; 298: 1217–9PubMedCrossRef
4.
5.
Chew EW, Bingham A, Burrows D. Incidence of acne vulgaris in patients with infantile acne. Clin Exp Dermatol 1990; 15: 374–7CrossRef
6.
Holland KT. The role of bacteria in acne vulgaris; a new approach. Clin Exp Dermatol 1978; 3: 263–7CrossRef
7.
Cunliffe WJ, Shuster S. The rate of sebum excretion in men. Br J Dermatol 1969: 81: 697–704PubMedCrossRef
8.
Swale V, Sasieni P, Macgregor A, et al. Heretability of common skin diseases using the twin model: a UK twin study. Br J Dermatol 1998; 139: 15–6CrossRef
9.
Gloor M, Hubscher M, Friederich HL. External treatment of acne vulgaris using tetracycline and estrogen [in German]. Hautarzt 1974; 25: 391–4PubMed
10.
Fulton JE, Plewig G, Kligman AM. Effect of chocolate on acne vulgaris. JAMA 1969; 210: 2071–4PubMedCrossRef
11.
Layton AM. Psychological aspects of acne vulgaris. J Cutan Med Surg 1998; 2Suppl. 3: 19–23PubMed
12.
Finlay AY, Khan GK. Dermatology life quality index (DLQI); a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210–6PubMedCrossRef
13.
Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol 1992; 17: 1–3PubMedCrossRef
14.
15.
Burke BM, Cunliffe WJ. The assessment of acne vulgaris: the Leeds technique. Br J Dermatol 1984; 111:82–93CrossRef
16.
Nacht S, Gans EH, McGinley KJ, et al. Comparative activity of benzoyl peroxide and hexachlorophene: in vivo studies against propionibacterium acnes in humans. Arch Dermatol 1983; 119: 577–9PubMedCrossRef
17.
Fulton JE, Farzad-Bakshandeth A. Studies on the mechanism of action of topical benzoyl peroxide in acne vulgaris. J Cutan Path 1974; 1: 191–200PubMedCrossRef
18.
Harnstein WF, Tegetmeyer L, Ziegler V. Allergic and irritant potential of benzoyl peroxide. Contact Dermatitis 1985; 13: 252–7CrossRef
19.
Holland KT, Bojar RA. Antimicrobial effects of azaleic acid. J Dermatol Treat 1993; 4Suppl. 1: S8–11CrossRef
20.
Mayer De Dilva A, Gollnick H, Detmar M, et al. Effects of azaleic acid on sebaceous glands, sebum excretion rate and keratinisation patterns in human skin. Acta Derm Venereol (Stockh) 1979; 143: 20–30
21.
Katsambas A, Graupe K, Stratigos J. Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris with vehicle and topical tretinoin. Acta Derm Venereol (Stockh) 1989; 143: 35–9
22.
Eady EA, Hope JH, Jones DN, et al. Topical antibiotics for the treatment of acne: a critical evaluation of the literature on their clinical benefit and comparative efficacy. J Dermatol Treat 1990; 1: 215–26CrossRef
23.
Thomas DR, Raimer S, Smith BE. Comparison of topical erythromycin 1.5% solution vs topical clindamycin phosphate 1 % solution in the treatment of acne vulgaris. Cutis 1982; 29: 624–32PubMed
24.
Esterley NB, Furey NL, Flaragan LE. The effect of antimicrobiological agents on leukocytes chemotaxis. J Invest Dermatol 1978; 70: 51–5CrossRef
25.
Eady EA, Jones CE, Tipper JL, et al. Antibiotic resistant propionibacteria in acne: need for policy for antibiotic usage. BMJ 1993; 306: 555–6PubMedCrossRef
26.
Chalker DK, Shalita AR, Smith JG, et al. A double blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris. J Am Acad Dermatol 1983; 9: 933–6PubMedCrossRef
27.
Christophers E, Wolfe HH. Effect of vitamin A acid on skin: in vivo and in vitro Studies. Acta Derm Venereol (Stockh) 1975; 74: 42–53
28.
Leyden J. Rational therapy for acne vulgaris: an update on topical treatment. J Am Acad Dermatol 1986; 15: 907–15PubMedCrossRef
29.
Shalita AR, Weiss JS, Chalker DK, et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicentre trial. J Am Acad Dermatol 1999; 34: 482–5CrossRef
30.
Schefer H. Penetration and percutaneous absorption of topical retinoids: a review. Skin Pharmacol 1993; 6: 17–23CrossRef
31.
Rietschel R, Duncan BS. Clindamycin phosphate used in combination with tretinoin in the treatment of acne. Int J Dermatol 1983; 22: 41–3PubMedCrossRef
32.
Mills OH, Kligman AM. Treatment of acne vulgaris with topically applied erythromycin and tretinoin. Acta Derm Venereol (Stockh) 1978; 58: 555–7
33.
Tucker SB, Tousend R, Cochrane R, et al. Comparison of topical clindamycin phosphate, benzoyl peroxide and a combination of the two in the treatment of acne vulgaris. Br J Dermatol 1984; 110: 487–92PubMedCrossRef
34.
Feucht CL, Allen BS, Chalker DK, et al. Topical erythromycin with zinc in acne: a double blind controlled study. J Am Acad Dermatol 1980; 3: 483–91PubMedCrossRef
35.
Hurwitz S. Combined effect of vitamin A acid and benzoyl peroxide in the treatment of acne. Cutis 1976; 17: 585–90PubMed
36.
Marples RR, Kligman AM. Ecological effects of oral antibiotics on the microflora of human skin. Arch Dermatol 1971; 103: 148–53PubMedCrossRef
37.
Cunliffe WJ, Cleydon AD, Gould D, et al. Acne vulgaris - its aetiology and treatment: a review. Clin Exp Dermatol 1981; 6: 461–9PubMedCrossRef
38.
Leyden JJ. Absorption of minocycline hydrochloride and tetracycline hydrochloride. J Am Acad Dermatol 1985; 12: 308–12PubMedCrossRef
39.
Bernier C, Dreno B. Minocycline. Ann Dermatol Venereol 2001; 128: 627–37PubMed
40.
Knaggs HE, Layton AM, Cunliffe WJ. The role of oral minocycline and erythromycin in tetracycline resistant acne: a retrospective study and a review. J Dermatol Treat 1993; 4: 53–6CrossRef
41.
Harrison TV. A comparison of doxycycline and minocycline in the treatment of acne vulgaris. Clin Exp Dermatol 1988; 13: 242–4PubMedCrossRef
42.
Bottomley WW, Cunliffe WJ. Oral trimethoprim as a third line antibiotic treatment in the management of acne vulgaris. Dermatology 1993; 187: 193–6PubMedCrossRef
43.
Eady EA, Jones CE, Gardner KJ, et al. Tetracycline resistant propionibacteria from acne patients are cross-resistant to doxycycline, but sensitive to minocycline. Br J Dermatol 1993; 128: 556–60PubMedCrossRef
44.
Miller YW, Eady EA, Vyakrnam S, et al. One in two close contacts of antibiotic treated acne patients carry resistant propionibacteria on their skin surface [abstract]. J Invest Dermatol 1997; 108: 379
45.
Eady EA, Cove JH, Holland KT, et al. Erythromycin resistant propionibacteria in antibiotic resistant acne. Br J Dermatol 1989; 121: 51–7PubMedCrossRef
46.
Eady EA, Farmery MR, Ross JI, et al. Effect of benzoyl peroxide and erythromycin alone and in combination against antibiotic sensitive and resistant skin bacteria from acne patients. Br J Dermatol 1994; 131: 331–6PubMedCrossRef
47.
Delaney TJ, Leopard BJ, Macdonald DM. Effects of long term treatment with tetracycline. Acta Derm Venereol (Stockh) 1975; 54: 487–9
48.
Layton AM, Cunliffe WJ. Phototoxic eruptions due to doxycycline: a dose related phenomenon. Clin Exp Dermatol 1993; 18: 425–7PubMedCrossRef
49.
Systemic antibiotics for the treatment of acne vulgaris: efficacy and safety. Ad Hoc Committee Report. Arch Dermatol 1975; 111: 1630–6
50.
Ray WA, Federspiel CF, Schaffner W. Prescribing of tetracycline to children less than 8 years. JAMA 1977; 237: 2069–74PubMedCrossRef
51.
Salter AJ. Trimethoprim/sulfamethoxazole: an assessment of more than twelve years use. Rev Infect Dis 1982; 4: 196–236PubMedCrossRef
52.
Somech R, Arav-Boger R, Assia A, et al. Complications of minocycline therapy for acne vulgaris: case report and review of the literature. Pediatr Dermatol 1999; 16: 469–72PubMedCrossRef
53.
Fanning WL, Gump DW, Sofferman RA. Side effects of minocycline; a double blind study. Antimicrob Agents Chemother 1977; 11: 712–7PubMedCrossRef
54.
Green D, Freedman KJ. Treatment of minocycline induced cutaneous pigmentation with the Q-switched Alexandrite laser and a review of the literature. J Am Acad Dermatol 2001; 44: 342–7PubMedCrossRef
55.
Hanstead B, Reymann F. Cyproterone acetate in the treatment of acne vulgaris in adult females. Dermatologica 1982; 164: 117–26CrossRef
56.
Thiboutot DM, Knaggs HE, Gilliland K, et al. Activity of type 1 5α-reductase is greater in the follicular infundibulum compared with the epidermis. Br J Dermatol 1997; 136: 166–71PubMedCrossRef
57.
Greenwood R, Brummitt L, Burke B, et al. Acne: a double blind clinical and laboratory trial of tetracycline, oestrogen, cyproterone acetate and combined treatment. BMJ 1985; 291: 1231–5PubMedCrossRef
58.
Layton AM, Cunliffe WJ. Guidelines for the optimal use of isotretinoin in acne. J Am Acad Dermatol 1992; 27 (6 Pt 2): S2–7PubMedCrossRef
59.
Cunliffe WJ, Van De Kerkhof PCM, Caputo R, et al. Roaccutane treatment guidelines: results of an international survey. Dermatology 1997; 194: 351–7PubMedCrossRef
60.
Cunliffe WJ. Treatment of acne. In: Marks R, editor. Acne and related disorders. London: M Dunitz, 1989: 266–76
61.
Colburn WA, Gibson DM, Wiens RE, et al. Food increases the bioavailability of isotretinoin. J Clin Pharmacol 1983; 23: 534–9PubMed
62.
Layton AM, Knaggs HE, Taylor J, et al. Isotretinoin for acne vulgaris — 10 years later: a safe and successful treatment. Br J Dermatol 1993; 129: 292–6PubMedCrossRef
63.
Harms M, Masooye I, Radeff B. The relapses of cystic acne after isotretinoin treatment are age related: a long term follow up study. Dermatologica 1986; 172: 148–53PubMedCrossRef
64.
Clark SM, Cunliffe WJ. Acne flare and isotretinoin: incidence and treatment [abstract]. Br J Dermatol 1995; 133: 26
65.
Karvone S. Acne fulminans: report of clinical findings and treatment of 24 patients. J Am Acad Dermatol 1993; 28: 572–9CrossRef
66.
Chivot M, Midoun H. Isotretinoin and acne: a study of relapses. Dermatologica 1990; 180: 240–3PubMedCrossRef
67.
Ellis CN, Krach KJ. Uses and complications of isotretinoin therapy. J Am Acad Dermatol 2001; 45: S150–7PubMedCrossRef
68.
Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy. N Engl J Med 1985; 313: 837–41PubMedCrossRef
69.
Dai WS, Hus MA, Itri LM. Safety of pregnancy after discontinuation of isotretinoin. Arch Dermatol 1989; 125: 362–5PubMedCrossRef
70.
Giovanna JJ. Isotretinoin effects on bone. J Am Acad Dermatol 2001; 45Suppl. 5: S176–82CrossRef
71.
Jacobs DG, Deutsch NL, Brewer M. Suicide, depression and isotretinoin: is there a causal link. J Am Acad Dermatol 2001; 45Suppl. 5: S168–75PubMedCrossRef
72.
Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139: 846–50PubMedCrossRef
73.
Staels B. Regulation of lipid and lipoprotein metabolism by retinoids. J Am Acad Dermatol 2001; 45Suppl. 5: S158–67PubMedCrossRef
74.
Pepall LM, Cosgrove MP, Cunliffe WJ. Ablation of whiteheads by cautery under topical anaesthetic. Br J Dermatol 1991; 125: 256–9PubMedCrossRef
75.
Orentreich N, Durr NP, Frank SB, editors. Acne. New York: Yorke Medical Books, 1979
76.
Yarborough JM. Scar revision by dermabrasion. In: Roenigk RK, Roenigk HH, editors. Dermatological surgery. New York: Marcel Dekker, 1989: 909–33
77.
78.
Kent A, Drummond LM. Acne excoriée: a case report using habit reversal. Clin Exp Dermatol 1989; 14: 163–4PubMedCrossRef
79.
80.
Carvone SL, Rasane L, Cunliffe WJ, et al. Delayed hypersensitivity to propionibacteria acnes in patients with severe nodular acne and acne fulminans. Dermatology 1994; 189: 344–9CrossRef
81.
Michelson HE, Allen PK. Acne conglobata. Arch Dermatol 1931; 23: 49–67CrossRef
82.
83.
Kligman AM, Mills OH. Acne cosmetica. Arch Dermatol 1970; 10: 843–50
84.
Kligman AM. A critical look at acne cosmetica. J Cutan Aging Cosmet Dermatol 1988; 1: 109–12
85.
Metadaten
Titel
Guidelines for the Management of Acne Vulgaris in Adolescents
verfasst von
Dr Victoria Goulden
Publikationsdatum
01.05.2003
Verlag
Springer International Publishing
Erschienen in
Pediatric Drugs / Ausgabe 5/2003
Print ISSN: 1174-5878
Elektronische ISSN: 1179-2019
DOI
https://doi.org/10.2165/00128072-200305050-00003

Weitere Artikel der Ausgabe 5/2003

Pediatric Drugs 5/2003 Zur Ausgabe

Therapy In Practice

Neurocardiogenic Syncope in Children

Current Opinion

Acute Gastroenteritis in Children

Therapy In Practice

Management of Peritonitis in Children Receiving Chronic Peritoneal Dialysis

Therapy In Practice

The Management of Idiopathic Nephrotic Syndrome in Children

Leading Article

Insulin Resistance Syndrome in Children

Neu im Fachgebiet Pädiatrie

23.04.2024 | Typ-1-Diabetes | Nachrichten

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

22.04.2024 | Fehlsichtigkeit | Nachrichten

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

18.04.2024 | Spinale Muskelatrophien | Nachrichten

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind
weitere anzeigen

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen